Methyl 3-(hydroxymethyl)benzoate, 95.0%, 100mg

Ethyl 2-(dimethylaminomethyl)-4-thiazolecarboxylate, 95.0%, 250mg

(2E)-1-(2,4-dimethoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

Foglio di lamiera 99,99% 2,0 x 100 x 100 mm 1 pz

(1Z)-N'-Hydroxy-3-(4-methyl-1-piperazinyl)propanimidamide, 95.0%, 5g

(1-BROMOCYCLOPROPYL)METHANOL, 95%, 100mg

Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:2), 99%, 25g

(3R)-3-(2-METHOXYETHOXY)PYRROLIDINE HCL, 95.0%, 10g

Iminostilbene>98.0%(GC)(N)5g

(4-(N-Butyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid, 95.0%, 1g

5-Ethynyl-2'-deoxyuridine>98.0%(HPLC)(T)200mg

Colonna capillare per GC ROTI®Cap-1, 10 m, 0.53 mm, 5.00 µm, 1 Pezzo(i)

Tetrahydro-2H-pyran-3-amine, 95.0%, 1g